Kyrgyzstan vs Nepal: Cases started on MDR-TB treatment
Kyrgyzstan
725
in 2024
Nepal
633
in 2024
Kyrgyzstan rank
25th
Nepal rank
26th
Cases started on MDR-TB treatment over time
- Kyrgyzstan
- Nepal
How they compare
Kyrgyzstan currently reports 725 against 633 in Nepal, a difference of 92.
That makes Kyrgyzstan's figure about 1.1 times Nepal's.
Across all 16 years both countries report, Kyrgyzstan has been ahead every year.
Kyrgyzstan ranks 25th and Nepal ranks 26th of 193 countries.
Kyrgyzstan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Kyrgyzstan | Nepal | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 545 | 156 | 389 | Kyrgyzstan |
| 2010s | 1,011 | 340.2 | 671 | Kyrgyzstan |
| 2020s | 845.2 | 532.4 | 312.8 | Kyrgyzstan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cases started on mdr-tb treatment, Kyrgyzstan or Nepal?
- Kyrgyzstan, at 725 against 633 in Nepal as of 2024.
- What is the difference in cases started on mdr-tb treatment between Kyrgyzstan and Nepal?
- 92, with Kyrgyzstan ahead.
- How many years of comparable data are there for Kyrgyzstan and Nepal?
- 16 years are reported by both, from 2009 to 2024.
- How do Kyrgyzstan and Nepal rank globally for cases started on mdr-tb treatment?
- Kyrgyzstan ranks 25th and Nepal ranks 26th of 193 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Cases started on MDR-TB treatment. Statizoid refreshes it automatically from the source and publishes the full history for both places.